A SGLT2 inhibitor dapagliflozin prevents heart failure with preserved ejection fraction through activating mitophagy in ZDF diabetic rats

被引：0
|
作者：
Feng, B. [1 ]
Zhang, N. [2 ]
Shi, B. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Endocrinol & Metab, Suzhou, Peoples R China
[2] Nanjing Med Univ, Affiliated Soochow Hosp, Cardiol, Suzhou, Peoples R China
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
198
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
    Michael E. Nassif
    Sheryl L. Windsor
    Barry A. Borlaug
    Dalane W. Kitzman
    Sanjiv J. Shah
    Fengming Tang
    Yevgeniy Khariton
    Ali O. Malik
    Taiyeb Khumri
    Guillermo Umpierrez
    Sumant Lamba
    Kavita Sharma
    Sadiya S. Khan
    Lokesh Chandra
    Robert A. Gordon
    John J. Ryan
    Sunit-Preet Chaudhry
    Susan M. Joseph
    Chen H. Chow
    Manreet K. Kanwar
    Michael Pursley
    Elias S. Siraj
    Gregory D. Lewis
    Barry S. Clemson
    Michael Fong
    Mikhail N. Kosiborod
    Nature Medicine, 2021, 27 : 1954 - 1960
  • [2] The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
    Nassif, Michael E.
    Windsor, Sheryl L.
    Borlaug, Barry A.
    Kitzman, Dalane W.
    Shah, Sanjiv J.
    Tang, Fengming
    Khariton, Yevgeniy
    Malik, Ali O.
    Khumri, Taiyeb
    Umpierrez, Guillermo
    Lamba, Sumant
    Sharma, Kavita
    Khan, Sadiya S.
    Chandra, Lokesh
    Gordon, Robert A.
    Ryan, John J.
    Chaudhry, Sunit-Preet
    Joseph, Susan M.
    Chow, Chen H.
    Kanwar, Manreet K.
    Pursley, Michael
    Siraj, Elias S.
    Lewis, Gregory D.
    Clemson, Barry S.
    Fong, Michael
    Kosiborod, Mikhail N.
    NATURE MEDICINE, 2021, 27 (11) : 1954 - +
  • [3] SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction
    Jhund, Pardeep S.
    HEART FAILURE CLINICS, 2022, 18 (04) : 579 - 586
  • [4] Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
    Selvaraj, Senthil
    Patel, Shachi
    Sauer, Andrew J.
    Mcgarrah, Robert W.
    Jones, Philip
    Kwee, Lydia Coulter
    Windsor, Sheryl L.
    Ilkayeva, Olga
    Muehlbauer, Michael J.
    Newgard, Christopher B.
    Borlaug, Barry A.
    Kitzman, Dalane W.
    Shah, Sanjiv J.
    Margulies, Kenneth B.
    Husain, Mansoor
    Inzucchi, Silvio E.
    Mcguire, Darren K.
    Lanfear, David E.
    Javaheri, Ali
    Umpierrez, Guillermo
    Mentz, Robert J.
    Sharma, Kavita
    Kosiborod, Mikhail N.
    Shah, Svati H.
    CIRCULATION-HEART FAILURE, 2024, 17 (11)
  • [5] SGLT2 INHIBITOR PRESCRIPTION RATE FOR PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
    Kim, Justin
    Chakrala, Teja
    Prakash, Roshni
    Ghaffar, Umar
    Patel, Jaymin
    Dass, Bhagwan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 404 - 404
  • [6] SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction
    Julie Hias
    Laura Hellemans
    Karolien Walgraeve
    Jos Tournoy
    Lorenz Van der Linden
    Drugs & Aging, 2022, 39 : 185 - 190
  • [7] Sglt2 Inhibitors And The Clinical Conundrum Of Heart Failure With Preserved Ejection Fraction
    Sridhar, C.
    Krithika, C.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 2200 - 2204
  • [8] SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction - The New Frontier
    Aguiar-Neves, Ines
    Santos-Ferreira, Diogo
    Fontes-Carvalho, Ricardo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (01)
  • [9] Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction
    Clemmer, John S.
    Ward, Taylor J.
    Lirette, Seth T.
    ESC HEART FAILURE, 2023, 10 (03): : 2010 - 2018
  • [10] Effects of Global SGLT2 Knockout on Heart Failure with Preserved Ejection Fraction
    Fain, Margaret E.
    Misener, Sol
    Zhou, Yalu
    Rousselle, Thomas
    Mas, Valeria R.
    Quaggin, Susan E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345